Gastrointestinal drug may slow aging process

Studies conducted on animals have revealed that clioquinol can slow the aging process. The drug was used to treat diarrhoea and other gastrointestinal disorders.

But the startling revelation came to fore when it was found that it could reverse the progression of Alzheimer's, Parkinson's and Huntington's diseases. Scientists have various explanations as to how a single medicine could reverse the progress of three unrelated neurodegenerative disorders.

According to Dr. Siegfried Hekimi and colleagues at McGill's Department of Biology, the drug effects a protein called CLK-1, often informally called 'clock-1.' This might be the reason for slowing down the ageing process.

Clioquinol affects a gene. This gene when inhibited leads to decreasing the ageing speed. This could be the reason of the drug having an effect on a diversity of diseases that are all age-dependent.

Strangely enough the drug had been withdrawn from the market after it led to an outbreak of subacute myelo-optic neuropathy in Japan in 1960s. The physicians warn that "clioquinol can be a very toxic substance if abused, and far more research is required."

The real hazard of the drug lies in self treatment by the people. If people start self experimentation and buy the drug in bulk it could lead to disastrous results.

 

Latest News

Abigail Wants To Live To the Fullest
Keith Martin Is World’s Fattest Man
British Man Gives Birth to Boy!
Too Much Consumption of Calories for Elders Could Be Hazardous for Brain, Says S
Doubts Raised Over National Statistics’ Analysis of NHS
BMA Proposes Strategies to Deal with Shortage of Organ Donors
Mobile service will offer cancer advice in Plymouth later this month
Skin cancer drug ‘bexarotene’ reverses Alzheimer's in mice
David Cameron "at one" with Andrew Lansley over NHS changes
Morning-After Pill Machine at Shippensburg University
Gabrielle-Union
Sir Abraham Lincoln, Life and Truths